Atezolizumab with chemotherapy improves PFS in squamous NSCLC

Editor’s Choice for May 2018

The 2018 Myeloma Knowledge Exchange

Dealing with peripheral neuropathic pain in multiple myeloma

Incorporating patient perspective during myeloma treatment

Treating bone disease in multiple myeloma patients

Managing infections in patients with multiple myeloma

Clinical management of plasma cell leukaemia

Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy

AKT inhibitors in research and application

Reducing recurrence of advanced melanoma with pembrolizumab

Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.